Skip to content

HR 10628 · United States Congress · 119 · Billy

Skip to content

Home
/
Bills
/
United States Congress
/
119
/
HR 10628

United States Congress · 119 session · house

HR 10628Biosimilars Access and Affordability Act

Status: In committee
Latest action: 2026-09-28 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Primary sponsor: Rep. Langworthy, Nicholas A. [R-NY-23] (R)

Health

Track this bill

Sponsors

Rep. Langworthy, Nicholas A. [R-NY-23] (R) · sponsorprimary

Versions

Introduced in HouseSep 28, 2026

Legislative history

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy United States Congress bill RSS

Sep 28, 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 28, 2026
Introduced in House
Sep 28, 2026
Introduced in House
Sep 28, 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Official sources

Version 0PDF HTML XML

About this page

Is this the official United States Congress bill page?: No — this is Billy’s public legislative record for HR 10628. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track HR 10628, get alerts, annotate diffs, and export Word work product.